May 4 (Reuters) -
* Prometic announces $60 million bought deal offering to
fund strategic growth initiatives
* Prometic Life Sciences Inc says underwriters have agreed
to buy 19.4 million common shares in capital of corporation at a
price of $3.10 per share
Source text for Eikon: ID:nCCN1q7vlM
Further company coverage: PLI.TO
(Bengaluru Newsroom: +1-646-223-8780)